Abstract
Cerebral palsy is a neurodevelopmental disorder with lifelong consequences. It includes a group of disorders of movement and posture, attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often associated with disturbances of sensation, cognition, communication, perception, behavior, and by a seizure disorder. CP may be caused by several different etiologies causing insults to the developing brain at different stages of development. CP is a clinical diagnosis based on a thorough history (prenatal, perinatal, and postnatal), review of developmental milestones, and neurologic examination. The work-up may include neuroimaging, metabolic or genetic testing, and testing for specific disorders. Also, the work-up may include testing for the associated conditions and complications: intellectual disability (52%), epilepsy (45%), speech and language disorders (38%), vision defects (28%), and hearing impairments (12%). These children often need long-term multidisciplinary care and therapies and supports for educational and social functioning to optimize the outcome. The disorder may exhibit a wide spectrum of functioning. Although the approach to treatment and rehabilitation may be similar for most children with CP, a description of the condition based on neuroimaging, and metabolic or genetic testing, may help individualize treatment and also help better predict the associated morbidity and what to expect for a particular child.
References
Arneson CL, Durkin MS, Benedict RE, Kirby RS, Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS (2009) Prevalence of cerebral palsy: autism and developmental disabilities monitoring network, three sites, United States, 2004. Disabil Health J 2(1):45–48
Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, Stevenson R, Quality Standards Subcommittee of the American Academy of Neurology (2004) Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 62(6):851–863
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D (2005) Proposed definition and classification of cerebral palsy, April 2005. Executive Committee for the definition of cerebral palsy. Dev Med Child Neurol 47(8):571–576. Review
Bhasin TK, Brocksen S, Avchen RN, Van Naarden Braun K (2006) Prevalence of four developmental disabilities among children aged 8 years – Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. MMWR Surveill Summ 55(1): 1–9
Croen LA, Grether JK, Curry CJ, Nelson KB (2001) Congenital abnormalities among children with cerebral palsy: more evidence for prenatal antecedents. J Pediatr 138:804
de Vries LS, Eken P, Groenendaal F, van Haastert IC, Meiners LC (1993) Correlation between the degree of periventricular leukomalacia diagnosed using cranial ultrasound and MRI later in infancy in children with cerebral palsy. Neuropediatrics 24:263–268
Ellenberg JH, Nelson KB (2013) The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 55:210
Executive summary: neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists’ task force on neonatal encephalopathy. (2014) Obstet Gynecol 123:896
Grether JK, Nelson KB (1997) Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 278:207
Lee RW, Poretti A, Cohen JS, Levey E, Gwynn H, Johnston MV, Hoon AH (2014) Fatemi . A diagnostic approach for cerebral palsy in the genomic era. NeuroMolecular Med 16(4):821–844
McCormick A, Brien M, Plourde J, Wood E, Rosenbaum P, McLean J (2007) Stability of the gross motor function classification system in adults with cerebral palsy. Dev Med Child Neurol 49:265–269
McMichael G, Bainbridge MN, Haan E et al (2015) Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 20:176
Miller G, Clark GD (1998) The cerebral palsies: causes, consequences, and management. Butterworth-Heinemann, Boston
Moreno-De-Luca A, Ledbetter DH, Martin CL (2012) Genetic insights into the causes and classification of cerebral palsies. Lancet Neurol 11:283
Morris C, Bartlett D (2004) Gross motor function classification system: impact and utility. Dev Med Child Neurol 46:60–65
Msall ME, Limperopoulos C, Park JJ (2009) Neuroimaging and cerebral palsy in children. Minerva Pediatr 61(4):415–424
Nelson KB, Ellenberg JH (1978) Epidemiology of cerebral palsy. Adv Neurol 19:421–435
Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J, Cioni G, Damiano D, Darrah J, Eliasson AC, de Vries LS, Einspieler C, Fahey M, Fehlings D, Ferriero DM, Fetters L, Fiori S, Forssberg H, Gordon AM, Greaves S, Guzzetta A, Hadders-Algra M, Harbourne R, Kakooza-Mwesige A, Karlsson P, Krumlinde-Sundholm L, Latal B, Loughran-Fowlds A, Maitre N, McIntyre S, Noritz G, Pennington L, Romeo DM, Shepherd R, Spittle AJ, Thornton M, Valentine J, Walker K, White R, Badawi N (2017) Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr 171:897
O’Shea TM (2002) Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 8:135
Palisano RJ, Cameron D, Rosenbaum PL, Walter SD, Russell D (2006) Stability of the gross motor function classification system. Dev Med Child Neurol 48: 424–428
Paneth N, Hong T, Korzeniewski S (2006) The descriptive epidemiology of cerebral palsy. Clin Perinatol 33(2): 251–267
Prechtl HFR, Einspieler C, Cloni G, Bos AF, Ferrari F, Sontheimer D (1997) An early marker for neurological deficits after perinatal brain injury. Lancet 349: 1361–1363
Razek AAK, Kandell AY, Elsorogy LG, Elmongy A, Basett AA (2009) Disorders of cortical malformation: MR imaging features. Am J Neuroradiol 30(1):4–11
Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B (2007) A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 109:8–14
Schaefer GB (2008) Genetics considerations in cerebral palsy. Semin Pediatr Neurol 15:21
Segel R, Ben-Pazi H, Zeligson S et al (2015) Copy number variations in cryptogenic cerebral palsy. Neurology 84:1660
Whitehouse WP (2011) Metabolic testing in children with cerebral palsy: yield could be up to 20%. Dev Med Child Neurol 53(12):1160
Wu YW, Escobar GJ, Grether JK et al (2003) Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290:2677
Zhou J, Butler EE, Rose J (2017) Neurologic correlates of gait abnormalities in cerebral palsy: implications for treatment. Front Hum Neurosci 11:103
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Agarwal, S. (2019). When and How to Evaluate the Child with Possible Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-50592-3_16-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-50592-3_16-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50592-3
Online ISBN: 978-3-319-50592-3
eBook Packages: Springer Reference MedicineReference Module Medicine